These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 448901)

  • 1. Reserpine: no changes advised for now.
    JAMA; 1979 Jul; 242(3):224. PubMed ID: 448901
    [No Abstract]   [Full Text] [Related]  

  • 2. Reserpine.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():211-41. PubMed ID: 7009394
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: Reserpine and breast cancer: a perspective.
    Jick H
    JAMA; 1975 Aug; 233(8):896-7. PubMed ID: 1173902
    [No Abstract]   [Full Text] [Related]  

  • 4. Status report on saccharin in humans.
    Newell GR; Hoover RN; Kolbye AC
    J Natl Cancer Inst; 1978 Aug; 61(2):275-6. PubMed ID: 355646
    [No Abstract]   [Full Text] [Related]  

  • 5. [Contribution of experimental research to the chemotherapy of tumors].
    Franchi G
    Cancro; 1973; 26(4):221-3. PubMed ID: 4806177
    [No Abstract]   [Full Text] [Related]  

  • 6. Nitrites: FDA beats a surprising retreat.
    Smith RJ
    Science; 1980 Sep; 209(4461):1100-1. PubMed ID: 7403871
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug therapy of Parkinson disease and parkinson disease-like symptoms].
    Kehr W
    Arzneimittelforschung; 1981; Suppl 27():26-33. PubMed ID: 7197938
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the Xpa-deficient transgenic mouse model for short-term carcinogenicity testing: 9-month studies with haloperidol, reserpine, phenacetin, and D-mannitol.
    Lina BA; Woutersen RA; Bruijntjes JP; van Benthem J; van den Berg JA; Monbaliu J; Thoolen BJ; Beems RB; van Kreijl CF
    Toxicol Pathol; 2004; 32(2):192-201. PubMed ID: 15200157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retarding effect of reserpine on the cancerization of rat liver induced by diethylnitrosamine].
    Lacassagne A; Buu-Hoi NP; Giao NB; Ferrando R
    Bull Cancer; 1968; 55(1):87-9. PubMed ID: 4973645
    [No Abstract]   [Full Text] [Related]  

  • 10. Technical background information report on carcinogenesis bioassay of 1,2-dibromoethane (EDB).
    Clin Toxicol; 1979 Apr; 14(4):473-8. PubMed ID: 380885
    [No Abstract]   [Full Text] [Related]  

  • 11. The ED01 study: introduction, objectives, and experimental design.
    Cairns T
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):1-7. PubMed ID: 7365374
    [No Abstract]   [Full Text] [Related]  

  • 12. International Conference on Harmonisation: guidance on testing for carcinogenicity of pharmaceuticals. Notice. Food and Drug Administration, HHS.
    Fed Regist; 1998 Feb; 63(35):8983-6. PubMed ID: 12269370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fesults of the failure to perform adequate preclinical studies before administering new drugs to humans.
    Nestor JO
    S Afr Med J; 1975 Feb; 49(8):287-90. PubMed ID: 47186
    [No Abstract]   [Full Text] [Related]  

  • 14. Reserpine tumorigenic in rodents.
    FDA Drug Bull; 1983 Nov; 13(3):28-9. PubMed ID: 6653954
    [No Abstract]   [Full Text] [Related]  

  • 15. Stability of reserpine injections and tablets submitted by U.S. hospitals.
    Coffman HD; Crabbs WC; Kolinski RE; Page DP
    Am J Hosp Pharm; 1986 Jan; 43(1):103-9. PubMed ID: 3953579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Korean ginseng extract attenuates reserpine-induced orofacial dyskinesia and improves cognitive dysfunction in rats.
    Sanghavi CR; Barhate SA; Mahajan MS; Mohan M; Kasture SB
    Nat Prod Res; 2011 Apr; 25(7):704-15. PubMed ID: 20628966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental cancer: animal studies and assay procedures.
    Griffin AC
    Tex Rep Biol Med; 1978; 37():45-9. PubMed ID: 752984
    [No Abstract]   [Full Text] [Related]  

  • 18. Reserpine-induced central effects: pharmacological evidence for the lack of central effects of reserpine methiodide.
    Nammi S; Boini KM; Koppula S; Sreemantula S
    Can J Physiol Pharmacol; 2005 Jun; 83(6):509-15. PubMed ID: 16049551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors in the evaluation of 200 National Cancer Institute carcinogen bioassays.
    Chu KC; Cueto C; Ward JM
    J Toxicol Environ Health; 1981; 8(1-2):251-80. PubMed ID: 7328708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of l-dopa on the development of reserpine parkinsonism and the metabolism of catecholamines in rats].
    Samoĭlova ZT; Tret'iakova KA; Khaliutina LV
    Farmakol Toksikol; 1973; 36(5):684-7. PubMed ID: 4802196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.